Affinity Tag-Free Purification of SARS-CoV-2 N Protein and Its Crystal Structure in Complex with ssDNA
- PMID: 39766245
- PMCID: PMC11673995
- DOI: 10.3390/biom14121538
Affinity Tag-Free Purification of SARS-CoV-2 N Protein and Its Crystal Structure in Complex with ssDNA
Abstract
The nucleocapsid (N) protein is one of the four structural proteins in SARS-CoV-2, playing key roles in viral assembly, immune evasion, and stability. One of its primary functions is to protect viral RNA by forming the nucleocapsid. However, the precise mechanisms by which the N protein interacts with viral RNA and assembles into a nucleocapsid remain unclear. Compared to other SARS-CoV-2 components, targeting the N protein has several advantages: it exhibits higher sequence conservation, lower mutation rates, and stronger immunogenicity, making it an attractive target for antiviral drug development and diagnostics. Therefore, a detailed understanding of the N protein's structure is essential for deciphering its role in viral assembly and developing effective therapeutics. In this study, we report the expression and purification of a soluble recombinant N protein, along with a 1.55 Å resolution crystal structure of its nucleic acid-binding domain (N-NTD) in complex with ssDNA. Our structure revealed new insights into the conformation and interaction of the flexible N-arm, which could aid in understanding nucleocapsid assembly. Additionally, we identified residues that are critical for ssDNA interaction.
Keywords: COVID-19; N-terminal domain; SARS-CoV-2; X-ray crystallography; atomic-resolution structure; mass photometry; nucleocapsid protein; protein expression; protein purification; protein–DNA interactions.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures





Similar articles
-
A core network in the SARS-CoV-2 nucleocapsid NTD mediates structural integrity and selective RNA-binding.Nat Commun. 2024 Dec 9;15(1):10656. doi: 10.1038/s41467-024-55024-0. Nat Commun. 2024. PMID: 39653699 Free PMC article.
-
Modulation of biophysical properties of nucleocapsid protein in the mutant spectrum of SARS-CoV-2.Elife. 2024 Jun 28;13:RP94836. doi: 10.7554/eLife.94836. Elife. 2024. PMID: 38941236 Free PMC article.
-
Assembly of SARS-CoV-2 nucleocapsid protein with nucleic acid.Nucleic Acids Res. 2024 Jun 24;52(11):6647-6661. doi: 10.1093/nar/gkae256. Nucleic Acids Res. 2024. PMID: 38587193 Free PMC article.
-
Molecular characterization of SARS-CoV-2 nucleocapsid protein.Front Cell Infect Microbiol. 2024 May 23;14:1415885. doi: 10.3389/fcimb.2024.1415885. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38846351 Free PMC article. Review.
-
Unraveling the role of the nucleocapsid protein in SARS-CoV-2 pathogenesis: From viral life cycle to vaccine development.Int J Biol Macromol. 2024 Nov;279(Pt 2):135201. doi: 10.1016/j.ijbiomac.2024.135201. Epub 2024 Aug 30. Int J Biol Macromol. 2024. PMID: 39216563 Review.
Cited by
-
Purification and Inhibitor Screening of the Full-Length SARS-CoV-2 Nucleocapsid Protein.Molecules. 2025 Jun 20;30(13):2679. doi: 10.3390/molecules30132679. Molecules. 2025. PMID: 40649197 Free PMC article.
References
-
- Aleem A., Akbar Samad A.B., Vaqar S. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2024. Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19) - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous